Warburg Pincus is a leading sponsor of biotechnology and pharmaceutical companies globally. The firm has invested more than $1 billion to build more than 40 biotechnology and pharmaceutical companies spanning a broad range of technologies and stages of development. We seek investments characterized by outstanding management teams, innovative therapies to address important unmet medical needs and fundamental technologies capable of generating or enabling multiple products over time.
Warburg Pincus is a unique partner within the biotechnology and pharmaceuticals venture capital and private equity industry.
- Life Science Expertise
- Unparalleled Financial Resources
- Long-term Horizon
Today, we see tremendous opportunities to partner with innovators in the sector. We remain committed to our goal of helping the next generation of leaders build world-class biotechnology and pharmaceuticals companies.
The firm's unique, globally-integrated partnership ensures that all of our resources are committed to the success of each portfolio company. Regardless of an investment's stage of development, industry focus or geography — the right people, with the right experience, are available to every entrepreneur and management team.
